Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: Application of new methodology

  1. Garnett, S.A.
  2. Martin, M.
  3. Jerusalem, G.
  4. Petruzelka, L.
  5. Torres, R.
  6. Bondarenko, I.N.
  7. Khasanov, R.
  8. Verhoeven, D.
  9. Pedrini, J.L.
  10. Smirnova, I.
  11. Lichinitser, M.R.
  12. Pendergrass, K.
  13. Lindemann, J.P.O.
  14. Di Leo, A.
Aldizkaria:
Breast Cancer Research and Treatment

ISSN: 1573-7217,  0167-6806

Argitalpen urtea: 2013

Alea: 138

Zenbakia: 1

Orrialdeak: 149-155

Mota: Artikulua

DOI: 10.1007/S10549-012-2395-8 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus